Skip to content
FCF Fox Corporate Finance GmbH
FCF Fox Corporate Finance GmbH
  • About FCF
    • Business
    • History
    • Facts & Figures
    • Philosophy
  • Business Units
    • FCF MidCap
    • FCF SmallCap / Growth
    • FCF DeepTech
    • FCF Life Sciences
  • Team
    • Team
    • Career
  • References
    • Transactions
    • Testimonials
  • Research
    • FCF Mid/SmallCap Sector Research
      • FCF Automotive Supplier Market Study
      • FCF European Chemicals Market Study
      • FCF Forestry, Paper & Packaging Market Study
      • FCF Industrial Machinery Market Study
      • FCF European Infrastructure & Construction Market Study
      • FCF Logistics & Transportation Market Study
      • FCF Metals & Materials Market Study
      • FCF European Pharmaceutical Market Study
      • FCF TMT Market Study
    • FCF Mid/SmallCap Market Research
      • FCF Bank Monitor
      • FCF Interest & Corporate Loan Monitor
      • FCF IPO Market Monitor
      • FCF Valuation Monitor
    • FCF DeepTech Research
      • FCF Advanced Manufacturing Venture Capital Report
      • FCF CleanTech Venture Capital Report
      • FCF Robotics Venture Capital Report
    • FCF Life Sciences Research
      • FCF Life Sciences Venture Capital Monitor – Europe
      • FCF Biotech Venture Capital Monitor – USA
      • FCF Life Sciences Venture Capital Report
      • FCF Biotech Public Equity Monitor
      • FCF Life Sciences IPO Report
      • FCF Life Sciences SPAC Monitor
      • FCF MedTech & Diagnostics Public Equity Monitor
  • News & Events
    • Events
    • FCF Fremdkapital-Tag
    • MYFS
    • News
  • Contact
    • Subscribe newsletter
FCF Fox Corporate Finance GmbH
  • About FCF
    • Business
    • History
    • Facts & Figures
    • Philosophy
  • Business Units
    • FCF MidCap
    • FCF SmallCap / Growth
    • FCF DeepTech
    • FCF Life Sciences
  • Team
    • Team
    • Career
  • References
    • Transactions
    • Testimonials
  • Research
    • FCF Mid/SmallCap Sector Research
      • FCF Automotive Supplier Market Study
      • FCF European Chemicals Market Study
      • FCF Forestry, Paper & Packaging Market Study
      • FCF Industrial Machinery Market Study
      • FCF European Infrastructure & Construction Market Study
      • FCF Logistics & Transportation Market Study
      • FCF Metals & Materials Market Study
      • FCF European Pharmaceutical Market Study
      • FCF TMT Market Study
    • FCF Mid/SmallCap Market Research
      • FCF Bank Monitor
      • FCF Interest & Corporate Loan Monitor
      • FCF IPO Market Monitor
      • FCF Valuation Monitor
    • FCF DeepTech Research
      • FCF Advanced Manufacturing Venture Capital Report
      • FCF CleanTech Venture Capital Report
      • FCF Robotics Venture Capital Report
    • FCF Life Sciences Research
      • FCF Life Sciences Venture Capital Monitor – Europe
      • FCF Biotech Venture Capital Monitor – USA
      • FCF Life Sciences Venture Capital Report
      • FCF Biotech Public Equity Monitor
      • FCF Life Sciences IPO Report
      • FCF Life Sciences SPAC Monitor
      • FCF MedTech & Diagnostics Public Equity Monitor
  • News & Events
    • Events
    • FCF Fremdkapital-Tag
    • MYFS
    • News
  • Contact
    • Subscribe newsletter

Blog

Longevity on the rise – Constant growth in the US and its arrival in Europe

2022-08-09 - IOTW - Longevity

The significant growth of transaction volumes and the number of deals closed from 2017 to 2021 confirms the increasing importance of longevity in the US and Europe. For both markets, the number of deals almost … Read more

Funding for Genomics exceeds all other subsectors in the ‘OMX-space

Genomics-Funding-Volume.

Genomics represents the most crucial pillar in the ‘OMX-space and is the largest subsector in the US and Europe (EUR 13.3bn vs. EUR 1.8bn). The second and third largest subsectors are microbiomics and proteomics for … Read more

A continued downward spiral of financing volumes for life sciences in the US

IOTW-Comparison-of-Investment-Volumes-First-Half-of-the-Year-US

A recent FCF Life Sciences analysis showed a significant decline in funding volumes for European life sciences markets in the first half of 2022 compared to 2021. This trend is now confirmed for the US … Read more

Significant decline of financing volumes for life sciences across all stages in Europe

Comparison-of-Life-Sciences-Investment-Volumes-First-Half-of-the-Year

During the first six months of 2022, we find that the funding for life sciences markets declined significantly compared to 2021. The trend affects all relevant life sciences subsectors of Biotech, HealthTech, and MedTech. The … Read more

Significant cooldown of venture capital financing for European life sciences markets

Sentiment_cooldown

Venture capital deal volumes in the European life sciences sector reached a record-breaking level in 2021. However, financing volumes decreased significantly by 29% in the first four months of 2022 compared to 2021.   Our … Read more

German CVC as most active corporate investor in the European life sciences sector

With 44 deals, the corporate venture arm of Boehringer Ingelheim was the most active corporate investor in the European life science market in the last five years. The only other investor having reached the top … Read more

Overview of top VC investors in European life sciences markets

It is no surprise that the top 5 European investors have shown significantly higher activities than US investors in Europe from 2017 to 2021. Nevertheless, US investors such as SOSV, Epidarex Capital, OrbiMed, and RA … Read more

Significant cool-down of BioTech IPOs in Europe and the US

The capital raised in BioTech IPOs declined heavily in Europe and the US. For Q4’21 – Q1’22, the amount of raised capital declined by 73 percent compared to Q4’20 – Q1’21 (from EUR 5,941m to … Read more

Chinese VCs continue to thrive on the European Healthcare market

Investors from China continue to show exceptional interest in young life science companies based in Europe. Investments made by Chinese VCs have significantly grown 17-fold over the last five years (from EUR 34m in 2017 … Read more

VC Markets for regenerative medicine continue strong growth in the US and Europe

Venture capital markets continue to show high interest in companies with a focus on regenerative medicine from Europe and the US. Since 2017 the market has shown exceptional growth, as funding volumes increased threefold to … Read more

Post navigation
Older posts
Page1 Page2 … Page5 Next →

Unsere letzten Beiträge

  • Venture Capital Sentiment Tracker – July 2022
  • Longevity on the rise – Constant growth in the US and its arrival in Europe
  • FCF Biotech Venture Capital Monitor – USA 06/2022 published
  • FCF Logistics & Transportation Market Study – 2022 published
  • Funding for Genomics exceeds all other subsectors in the ‘OMX-space
  • Life Sciences Venture Capital Monitor – Europe 06/2022 published
  • Venture Capital Sentiment Tracker – June 2022
  • FCF Valuation Monitor – Q2 2022 published
  • A continued downward spiral of financing volumes for life sciences in the US
  • FCF Biotech Venture Capital Monitor – USA 05/2022 published
FCF Fox Corporate Finance GmbH • Maximilianstr. 12-14 • 80539 Munich, Germany • T: +49-89-20 60 409-0 • Imprint • Data Protection • LinkedIn • Xing
Scroll Up